160 related articles for article (PubMed ID: 35411759)
1. Overcoming reward deficiency syndrome by the induction of "dopamine homeostasis" instead of opioids for addiction: illusion or reality?
Blum K; Soni D; Badgaiyan RD; Baron D
J Osteopath Med; 2022 Apr; 122(7):333-337. PubMed ID: 35411759
[TBL] [Abstract][Full Text] [Related]
2. Conceptualizing Addiction From an Osteopathic Perspective: Dopamine Homeostasis.
Baron D; Blum K; Chen A; Gold M; Badgaiyan RD
J Am Osteopath Assoc; 2018 Feb; 118(2):115-118. PubMed ID: 29379966
[TBL] [Abstract][Full Text] [Related]
3. Hypothesizing That Neuropharmacological and Neuroimaging Studies of Glutaminergic-Dopaminergic Optimization Complex (KB220Z) Are Associated With "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).
Blum K; Febo M; Fried L; Li M; Dushaj K; Braverman ER; McLaughlin T; Steinberg B; Badgaiyan RD
Subst Use Misuse; 2017 Mar; 52(4):535-547. PubMed ID: 28033474
[TBL] [Abstract][Full Text] [Related]
4. Molecular neurological correlates of endorphinergic/dopaminergic mechanisms in reward circuitry linked to endorphinergic deficiency syndrome (EDS).
Blum K; Baron D; McLaughlin T; Gold MS
J Neurol Sci; 2020 Apr; 411():116733. PubMed ID: 32088516
[TBL] [Abstract][Full Text] [Related]
5. A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration.
Blum K; Kazmi S; Modestino EJ; Downs BW; Bagchi D; Baron D; McLaughlin T; Green R; Jalali R; Thanos PK; Elman I; Badgaiyan RD; Bowirrat A; Gold MS
J Pers Med; 2021 Mar; 11(3):. PubMed ID: 33809702
[TBL] [Abstract][Full Text] [Related]
6. Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions.
Blum K; Bowirrat A; Braverman ER; Baron D; Cadet JL; Kazmi S; Elman I; Thanos PK; Badgaiyan RD; Downs WB; Bagchi D; Llanos-Gomez L; Gold MS
Int J Environ Res Public Health; 2021 Nov; 18(21):. PubMed ID: 34770047
[TBL] [Abstract][Full Text] [Related]
7. DNA Directed Pro-Dopamine Regulation Coupling Subluxation Repair, H-Wave
Bajaj A; Blum K; Bowirrat A; Gupta A; Baron D; Fugel D; Nicholson A; Fitch T; Downs BW; Bagchi D; Dennen CA; Badgaiyan RD
J Pers Med; 2022 Aug; 12(9):. PubMed ID: 36143203
[TBL] [Abstract][Full Text] [Related]
8. Pro-Dopamine Regulator - (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome (RDS).
Blum K; Febo M; Fried L; Baron D; Braverman ER; Dushaj K; Li M; Demetrovics Z; Badgaiyan RD
J Reward Defic Syndr Addict Sci; 2017; 3(1):3-13. PubMed ID: 28804788
[TBL] [Abstract][Full Text] [Related]
9. A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing "Precision Behavioral Management".
Blum K; Steinberg B; Gondre-Lewis MC; Baron D; Modestino EJ; Badgaiyan RD; Downs BW; Bagchi D; Brewer R; McLaughlin T; Bowirrat A; Gold M
Psychol Res Behav Manag; 2021; 14():2115-2134. PubMed ID: 34949945
[TBL] [Abstract][Full Text] [Related]
10. Fifty Years in the Development of a Glutaminergic-Dopaminergic Optimization Complex (KB220) to Balance Brain Reward Circuitry in Reward Deficiency Syndrome: A Pictorial.
Blum K; Febo M; Badgaiyan RD
Austin Addict Sci; 2016; 1(2):. PubMed ID: 27840857
[TBL] [Abstract][Full Text] [Related]
11. Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): Do homo sapiens acquire or have a reward deficiency syndrome?
Gold MS; Baron D; Bowirrat A; Blum K
J Neurol Sci; 2020 Nov; 418():117137. PubMed ID: 32957037
[TBL] [Abstract][Full Text] [Related]
12. Pro-Dopamine Regulator (KB220) A Fifty Year Sojourn to Combat Reward Deficiency Syndrome (RDS): Evidence Based Bibliography (Annotated).
Kenneth B; Edward MJ; Marjorie GLC; David B; Bruce S; Panayotis TK; William DB; Davis S; Lisa L; Eric BR; Mark M; David M; Lyle F; Rajendra BD
CPQ Neurol Psychol; 2018; 1(2):. PubMed ID: 30957097
[TBL] [Abstract][Full Text] [Related]
13. Would induction of dopamine homeostasis via coupling genetic addiction risk score (GARS®) and pro-dopamine regulation benefit benzodiazepine use disorder (BUD)?
Blum K; Gold M; Modestino EJ; Baron D; Boyett B; Siwicki D; Lott L; Podesta A; Roy AK; Hauser M; Downs BW; Badgaiyan RD
J Syst Integr Neurosci; 2018 May; 4():. PubMed ID: 31750006
[TBL] [Abstract][Full Text] [Related]
14. Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?
Blum K; Dennen CA; Elman I; Bowirrat A; Thanos PK; Badgaiyan RD; Downs BW; Bagchi D; Baron D; Braverman ER; Gupta A; Green R; McLaughlin T; Barh D; Gold MS
J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294858
[TBL] [Abstract][Full Text] [Related]
15. Molecular role of dopamine in anhedonia linked to reward deficiency syndrome (RDS) and anti- reward systems.
Gold MS; Blum K; Febo M; Baron D; Modestino EJ; Elman I; Badgaiyan RD
Front Biosci (Schol Ed); 2018 Mar; 10(2):309-325. PubMed ID: 29293435
[TBL] [Abstract][Full Text] [Related]
16. The Future is Now for Precision Genomic Addiction Medicine as a Frontline Modality for Inducing "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).
Gilley ED; Bowirrat A; Gupta A; Giordano J; A Dennen C; R Braverman E; D Badgaiyan R; McLaughlin T; Baron D; Blum K
Curr Pharm Biotechnol; 2023 Apr; ():. PubMed ID: 37102488
[TBL] [Abstract][Full Text] [Related]
17. Death by Opioids: Are there non-addictive scientific solutions?
Downs BW; Blum K; Baron D; Bowirrat A; Lott L; Brewer R; Boyett B; Siwicki D; Roy AK; Podesta A; Badgaiyan S; Hajela R; Fried L; Badgaiyan RD
J Syst Integr Neurosci; 2019 Jun; 5():. PubMed ID: 31824737
[TBL] [Abstract][Full Text] [Related]
18. Putative COVID- 19 Induction of Reward Deficiency Syndrome (RDS) and Associated Behavioral Addictions with Potential Concomitant Dopamine Depletion: Is COVID-19 Social Distancing a Double Edged Sword?
Blum K; Cadet JL; Baron D; Badgaiyan RD; Brewer R; Modestino EJ; Gold MS
Subst Use Misuse; 2020; 55(14):2438-2442. PubMed ID: 32957797
[TBL] [Abstract][Full Text] [Related]
19. The Food and Drug Addiction Epidemic: Targeting Dopamine Homeostasis.
Blum K; Thanos PK; Wang GJ; Febo M; Demetrovics Z; Modestino EJ; Braverman ER; Baron D; Badgaiyan RD; Gold MS
Curr Pharm Des; 2018 Feb; 23(39):6050-6061. PubMed ID: 28831923
[TBL] [Abstract][Full Text] [Related]
20. Should We Embrace the Incorporation of Genetically Guided "Dopamine Homeostasis" in the Treatment of Reward Deficiency Syndrome (RSD) as a Frontline Therapeutic Modality?
Blum K; Raza A; Schultz T; Jalali R; Green R; Brewer R; Thanos PK; McLaughlin T; Baron D; Bowirrat A; Elman I; Downs BW; Bagchi D; Badgaiyan RD
Acta Sci Neurol; 2021 Feb; 4(2):17-24. PubMed ID: 33681869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
